Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
RenovoRx, Inc. is a life sciences company specializing in targeted drug delivery for difficult-to-treat cancers. Its core product, RenovoCath, is an FDA-cleared device utilizing the proprietary TAMP platform to precisely deliver chemotherapy directly to tumors, minimizing systemic toxicity. The company develops innovative drug-device combinations, with a focus on pancreatic and other solid tumors, serving oncology and interventional radiology markets through clinical trials and commercialization efforts.
This description was generated via AI from an annual report. Updated about 1 year ago.